New hip implant coating aims to cut infection risk and boost bone bonding

NCT ID NCT03113981

Ongoing Disease control Sponsor: Societe ACTIVBIOMAT Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new coating on a hip replacement implant that may help prevent infections and help the implant bond better with the bone. About 340 adults needing a hip replacement will receive either the coated or standard implant. The goal is to see if the coated implant works as well or better than the standard one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASEPTIC OSTEONECROSIS OF THE FEMORAL HEAD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

avascular necrosis of femoral head, primary, 1 idiopathic avascular necrosis infertility disorder Neoplasm Metastasis osteoarthritis, hip osteonecrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COXARTHROSIS; PRIMARY COXARTHROSIS; SECONDARY HIP ARTHROPLASTY HIP ARTHROPLASTY REPLACEMENT HIP ARTHROPLASTY, TOTAL OSTEOARTHRITIS, HIP OSTEONECROSIS; ASEPTIC, IDIOPATHIC

Contacts and locations

Show contact details

Locations

CH Privé Brestois et Clinique Pasteur

Brest, 29200, France
CH de Cornouaille

Quimper, 29107, France
CHU Cavale Blanche

Brest, 29200, France
CHU de Bordeaux Site Pellegrin

Bordeaux, 33076, France
HUS

Strasbourg, 67200, France
Hopital Ambroise Pare

Boulogne-Billancourt, 92000, France
Hôpital Lariboisière

Paris, 75010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.